Continuation of Research and Development Activities
First written in FY2018-Q1. 15 of 28 entries say "Restated". Latest entry: FY2026.
26 other companies' latest entry also says "Other".
- FY2026Decrease in R&D expensesAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥1,271 million.」
R&D activities continued, with development of highly insulated products, aluminum-wood composite sashes, magnesium alloys and other products, but R&D expenses decreased from ¥1,312 million in the previous fiscal year to ¥1,271 million. - FY2026-H1AdvancedAnnual report
「The Group's total R&D expenses for the six months ended Q2 were ¥634 million.」
R&D activities continued, and R&D expenses for the first half increased from ¥604 million in the same period of the previous year to ¥634 million. - FY2025AdvancedAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥1,312 million.」
R&D expenses increased from ¥1,309 million in the previous fiscal year to ¥1,312 million. Development of highly insulated products, optical building materials, magnesium alloys and disaster prevention systems, among other products, is continuing. - FY2025-H1Decrease in interim R&D expenseAnnual report
「The Group's total R&D expenses for the six months ended Q2 were ¥604 million.」
R&D activities continued, but R&D expenses for the first half decreased from ¥644 million in the same period of the previous year to ¥604 million. - FY2024Slight decrease in R&D expensesAnnual report
「The Group's total R&D expenses for the consolidated fiscal year were ¥1,309 million.」
R&D activities continued, and R&D expenses edged down from ¥1,311 million in the previous fiscal year to ¥1,309 million. Development of highly insulated products, optical building materials, magnesium alloys and disaster prevention systems, among other products, is continuing. - FY2024-Q3Slight decrease in cumulative research and development expenditureAnnual report
「The Group's total R&D expenses for the nine months ended Q3 were ¥963 million. There were no material changes in the Group's R&D activities during the nine months ended Q3.」
Although there were no material changes in R&D activities, cumulative R&D expenses edged down from ¥964 million in the same period of the previous year to ¥963 million. - FY2024-Q2Slight decrease in first-half research and development expenditureAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥623 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
Although there were no material changes in R&D activities, R&D expenses decreased from ¥644 million in the same period of the previous year to ¥623 million. - FY2024-Q1Quarterly R&D expenses decreasedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥267 million.」
While stating that there were no material changes in the status of research and development activities, the Group reported that research and development expenditure decreased from ¥309 million in the same period of the previous year to ¥267 million. - FY2023RestatedAnnual report
「The Group's total research and development expenditure for the current consolidated fiscal year was ¥1,311 million.」
The Group continues its research and development activities, including the development of building materials, magnesium alloys, medical devices and environmentally friendly products. Research and development expenditure increased from ¥1,303 million in the previous fiscal year to ¥1,311 million. - FY2023-Q3Slight decrease in cumulative research and development expenditureAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥964 million.」
While stating that there were no material changes in the status of research and development activities, the Group reported that research and development expenditure decreased by ¥9 million from ¥973 million in the same period of the previous year to ¥964 million. - FY2023-Q2Decline in first-half research and development expensesAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥618 million.」
While stating that there were no material changes in the status of research and development activities, the Group reported that first-half research and development expenditure decreased from ¥644 million in the same period of the previous year to ¥618 million. - FY2023-Q1Quarterly R&D expenses decreasedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥275 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
While stating that there were no material changes in the status of research and development activities, the Group reported that research and development expenditure decreased from ¥309 million in the same period of the previous year to ¥275 million. - FY2022-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥973 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥973 million for the third quarter of the current cumulative period. It stated that there were no material changes in the status of these activities. - FY2022-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥644 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥644 million for the second quarter of the current cumulative period. - FY2022-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥309 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥309 million for the first quarter of the current cumulative period. It stated that there were no material changes in the status of these activities. - FY2021-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥1,130 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥1,130 million for the third quarter of the current cumulative period. It stated that there were no material changes in the status of these activities. - FY2021-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥735 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥735 million for the second quarter of the current cumulative period. It stated that there were no material changes in the status of these activities. - FY2021-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥357 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥357 million for the first quarter of the current cumulative period. It stated that there were no material changes in the status of these activities. - FY2020AdvancedAnnual report
「The Group's total research and development expenditure for the current consolidated fiscal year was ¥1,732 million.」
The Group continues its research and development activities, and research and development expenditure increased from ¥1,677 million to ¥1,732 million. The disclosure also describes the results of developing high-insulation products, light-transmitting building materials and magnesium alloys. - FY2020-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥1,252 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥1,252 million for the third quarter of the current consolidated cumulative period. It stated that there were no material changes in the status of these activities. - FY2020-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥826 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥826 million for the second quarter of the current cumulative period. It stated that there were no material changes in the status of these activities. - FY2020-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥419 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥419 million for the first quarter of the current consolidated cumulative period. It stated that there were no material changes in the status of these activities. - FY2019RestatedAnnual report
「The Group's total research and development expenditure for the current consolidated fiscal year was ¥1,677 million.」
The Group continues its research and development activities, with total research and development expenditure for the current fiscal year amounting to ¥1,677 million. The disclosure also describes the development status of high-insulation products, light-transmitting building materials and magnesium alloys. - FY2019-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥759 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥759 million for the second quarter of the current consolidated cumulative period. It stated that there were no material changes in the status of these activities. - FY2019-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥368 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥368 million for the first quarter of the current consolidated cumulative period. - FY2018-Q3RestatedAnnual report
「The Group's total research and development expenditure for the third quarter of the current consolidated cumulative period was ¥1,099 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥1,099 million for the third quarter of the current consolidated cumulative period. It stated that there were no material changes in the status of these activities. - FY2018-Q2RestatedAnnual report
「The Group's total research and development expenditure for the second quarter of the current consolidated cumulative period was ¥718 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
The Group continues its research and development activities and disclosed research and development expenditure of ¥718 million for the second quarter of the current consolidated cumulative period. - FY2018-Q1First statedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated cumulative period was ¥382 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
Research and development expenditure for the first quarter of the current consolidated cumulative period was disclosed as ¥382 million, with no material changes in the status of research and development activities.